India's Medicine &' Antibiotics Exports Surge in US, Italy
Aug 15, 2024 18:44
India's pharmaceutical exports are booming, with significant gains in the US and Italian markets for medicine and antibiotics. This growth is attributed to government initiatives to boost domestic manufacturing.
New Delhi, Aug 15 (PTI) With the government focusing on boosting domestic manufacturing of pharmaceutical products, India's medicine and antibiotics exports have started gaining significant market share in the US.
According to the commerce ministry data, India is the third largest import source of 'medicine put up for retail sale' for the US. The top two are Ireland and Switzerland.
In 2023, the country exported these medicines worth USD 9 billion as against 7.33 billion in 2022.
With this increase in the shipments, India's share went up to 13.1 per cent in 2023 from 10.08 per cent in 2022. Share of the top exporter Ireland fell to 13.85 per cent in 2023 from 17.18 per cent in 2022 because its sales in the US went down to USD 9.5 billion in 2023 from USD 12.5 billion in 2022.
The second biggest exporter Switzerland also saw its share decline to 13.7 per cent last year from 17.4 per cent in 2022.
Similarly, India has increased its share among exporters of antibiotics in the Italian market. It is ranked 10th in that market by increasing its share to 2.12 per cent in 2023 from 0.96 per cent in 2022.
In value terms, the country's antibiotics exports to Italy stood at USD 23.34 million in 2023 as against USD 11.48 million in 2022.
Further the data showed that India's competitiveness is growing in the Magnetic Resonance Imaging (MRI) apparatus market of Germany.
In 2023, the country made a small gain by increasing its export share in Germany to 1.7 per cent from 0.45 per cent in 2022.
In value terms, India exported theseI machines worth USD 13.02 million last year as against USD 2.93 million in 2022.
India is the sixth largest exporter ofI apparatus, whereas the UK is the leader with exports of USD 460 million.
"Penetrating the EU market is difficult and it is important that we have a base coming in. These reflect some efforts which are being put in terms of monitoring various markets and various commodities to see where growth can be pushed," an official said.
Pharma and medical devices manufacturing is the priority area for the government and these two sectors were the first ones to get a Production Linked Incentive (PLI) scheme.
Home »
Market News » India's Medicine &' Antibiotics Exports Surge in US, Italy
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
MORE NEWS
Samsung Galaxy S25: India Manufacturing, AI...
Samsung's new Galaxy S25 series will be manufactured in India, boasts enhanced AI...
Maharashtra Inks Rs 15 Lakh Cr MoUs at Davos
Maharashtra government signs 54 MoUs worth Rs 15.70 lakh crore at Davos, including a Rs...
Karnataka Unveils New Industrial, EV Policies...
Karnataka will announce new industrial, EV and clean mobility policies at the Karnataka...
Responsible AI Challenges: HCLTech-MIT Study
HCLTech and MIT study reveals challenges in adopting responsible AI, highlighting...
Go Digit Q3 Net Profit Soars 3-fold to Rs 119...
Go Digit's net profit for Q3 FY25 surged by almost 300% to Rs 119 crore, driven by...
India's Digital Potential: Key to Inclusive...
KPMG report highlights India's digital potential for inclusive growth and becoming a...
JSW UAV to Set Up Rs 800 Crore Facility in...
JSW UAV Ltd. has signed an MoU with the Telangana government to establish a...
India Aims for 10,000 GI Products by 2030
India's Commerce Minister sets an ambitious target to register 10,000 Geographical...
Wadhawan Port: India Aims for Top 10 Container...
Union Minister Sonowal highlights Wadhawan Port's potential to elevate India to the top...
HUDCO Q3 Net Profit Surges 42% to Rs 735 Cr
HUDCO's consolidated net profit for the December quarter rose 42% to Rs 735.03 crore,...
Read More »